Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group - PubMed (original) (raw)
Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group
D A Antonetti et al. Diabetes. 1998 Dec.
Abstract
Blood-retinal barrier (BRB) breakdown is a hallmark of diabetic retinopathy, but the molecular changes that cause this pathology are unclear. Occludin is a transmembrane component of interendothelial tight junctions that may regulate permeability at the BRB. In this study, we examined the effects of vascular endothelial growth factor (VEGF) and diabetes on vascular occludin content and barrier function. Sprague-Dawley rats were made diabetic by intravenous streptozotocin injection, and age-matched animals served as controls. After 3 months, BRB permeability was quantified by intravenous injection of fluorescein isothiocyanate-bovine serum albumin (FITC-BSA), Mr 66 kDa, and 10-kDa rhodamine-dextran (R-D), followed by digital image analysis of retinal sections. Retinal fluorescence intensity for FITC-BSA increased 62% (P < or = 0.05), but R-D fluorescence did not change significantly. Occludin localization at interendothelial junctions was confirmed by immunofluorescence, and relative protein content was determined by immunoblotting of retinal homogenates. Retinal occludin content decreased approximately 35% (P < or = 0.03) in the diabetic versus the control animals, whereas the glucose transporter GLUT1 content was unchanged in rat retinas. Additionally, treatment of bovine retinal endothelial cells in culture with 0.12 nmol/l or 12 nmol/l VEGF for 6 h reduced occludin content 46 and 54%, respectively. These data show that diabetes selectively reduces retinal occludin protein expression and increases BRB permeability. Our findings suggest that the elevated VEGF in the vitreous of patients with diabetic retinopathy increases vascular permeability by downregulating occludin content. Decreased tight junction protein expression may be an important means by which diabetes causes increased vascular permeability and contributes to macular edema.
Similar articles
- VEGF164 is proinflammatory in the diabetic retina.
Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP. Ishida S, et al. Invest Ophthalmol Vis Sci. 2003 May;44(5):2155-62. doi: 10.1167/iovs.02-0807. Invest Ophthalmol Vis Sci. 2003. PMID: 12714656 - Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S, Yang Q, Hou M, Han Q, Zhang H, Wang J, Qi C, Bo Q, Ru Y, Yang W, Gu Z, Wei R, Cao Y, Li X, Zhang Y. Cai S, et al. Cell Physiol Biochem. 2018;45(2):505-522. doi: 10.1159/000487029. Epub 2018 Jan 25. Cell Physiol Biochem. 2018. PMID: 29402864 - VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. Harhaj NS, et al. Invest Ophthalmol Vis Sci. 2006 Nov;47(11):5106-15. doi: 10.1167/iovs.06-0322. Invest Ophthalmol Vis Sci. 2006. PMID: 17065532 - Endothelial and glial cell interaction in diabetic retinopathy via the function of vascular endothelial growth factor (VEGF).
Sueishi K, Hata Y, Murata T, Nakagawa K, Ishibashi T, Inomata H. Sueishi K, et al. Pol J Pharmacol. 1996 May-Jun;48(3):307-16. Pol J Pharmacol. 1996. PMID: 9112668 Review. - The pathogenesis of edema in diabetic maculopathy.
Antcliff RJ, Marshall J. Antcliff RJ, et al. Semin Ophthalmol. 1999 Dec;14(4):223-32. doi: 10.3109/08820539909069541. Semin Ophthalmol. 1999. PMID: 10758223 Review.
Cited by
- Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.
Moon J, Kim M, Sagong M. Moon J, et al. Eye (Lond). 2016 Aug;30(8):1084-90. doi: 10.1038/eye.2016.96. Epub 2016 May 27. Eye (Lond). 2016. PMID: 27229707 Free PMC article. Clinical Trial. - A Pilot Study on MicroRNA Profile in Tear Fluid to Predict Response to Anti-VEGF Treatments for Diabetic Macular Edema.
Chan HW, Yang B, Wong W, Blakeley P, Seah I, Tan QSW, Wang H, Bhargava M, Lin HA, Chai CH, Mangunkusumo EA, Thet N, Yuen YS, Sethi R, Wang S, Hunziker W, Lingam G, Su X. Chan HW, et al. J Clin Med. 2020 Sep 10;9(9):2920. doi: 10.3390/jcm9092920. J Clin Med. 2020. PMID: 32927780 Free PMC article. - Retinal capillary basement membrane thickening: Role in the pathogenesis of diabetic retinopathy.
Roy S, Kim D. Roy S, et al. Prog Retin Eye Res. 2021 May;82:100903. doi: 10.1016/j.preteyeres.2020.100903. Epub 2020 Sep 18. Prog Retin Eye Res. 2021. PMID: 32950677 Free PMC article. Review. - Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction.
Hammer SS, Vieira CP, McFarland D, Sandler M, Levitsky Y, Dorweiler TF, Lydic TA, Asare-Bediako B, Adu-Agyeiwaah Y, Sielski MS, Dupont M, Longhini AL, Li Calzi S, Chakraborty D, Seigel GM, Proshlyakov DA, Grant MB, Busik JV. Hammer SS, et al. Diabetologia. 2021 Jul;64(7):1674-1689. doi: 10.1007/s00125-021-05431-5. Epub 2021 Mar 26. Diabetologia. 2021. PMID: 33770194 Free PMC article. - Current and future approaches in the prevention and treatment of diabetic retinopathy.
Chang LK, Sarraf D. Chang LK, et al. Clin Ophthalmol. 2008 Jun;2(2):425-33. doi: 10.2147/opth.s736. Clin Ophthalmol. 2008. PMID: 19668733 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous